UPDATE 1-Merck-NewLink Ebola vaccine Phase III trial to start March 7
March 05, 2015 at 05:38 AM EST
GENEVA/LONDON, March 5 (Reuters) - Final stage of testing of an experimental Ebola vaccine being developed by Merck and NewLink Genetics will begin in Guinea on March 7, the World Health Organization said on Thursday.
